Tata Capital looking to exit Sai Life Sciences; Top PE funds in the race

Around 35% stake of the Hyderabad-based firm is being sold. General Atlantic, Warburg Pincus, Apax Partners and Temasek among interested bidders.

Source: The Economic Times Healthcare and Biotech News - March 17, 2018 Category: Pharmaceuticals Source Type: news